Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Don Cilla, Pharm.D., M.B.A.

Chief Development Officer
Appili Therapeutics

Disclosure(s): Appili Therapeutics: Employee, Stocks/Bonds

Poster(s):

605 - Efficacy and pharmacokinetics-pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET